Sema4|genedx to participate in the 41st annual j.p. morgan healthcare conference

Stamford, conn., dec. 30, 2022 (globe newswire) -- sema4 (nasdaq: smfr), a health insights company, today announced the company will participate in the 41st annual j.p. morgan healthcare conference in san francisco. katherine stueland, president and chief executive officer, will deliver a formal presentation on thursday, january 12, 2023, at 10:30 a.m. pt.
SMFR Ratings Summary
SMFR Quant Ranking